With FDA approval of EpidiolexR, the pace of research on CBD medication is likely to increase.
With FDA approval of EpidiolexR, the pace of research on CBD medication is likely to increase.
A new study shows that cannabidiol is effective in children with Lennox-Gastaut syndrome.
Two studies demonstrate clinically significant response to oral liquid cannabidiol over placebo.
A quality improvement project with relatively simple interventions resulted in a significant decrease in Emergency Department visits and inpatient admissions, while saving $2 million in health care costs.
Surgery proves to be a viable option for patients with medically refractory epilepsy.
